 |
인쇄하기
취소
|
Pacific Pharma faces suspension or delisting for non-compliance
Korea Exchange, the country’s bourse operator, announced on Thursday it may suspend the trading of Pacific Pharma shares from July 1 due to their non-compliance to the Listing Act clauses.
KRX said that from the company’s 2,328,947 floating shares, 95,903 shares only had been traded during the January-May period.
Thus the company faces a June 30 deadline to meet stock exchange requirement...
KRX said that from the company’s 2,328,947 floating shares, 95,903 shares only had been traded during the January-May period.
Thus the company faces a June 30 deadline to meet stock exchange requirement...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.